Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat

Journal of Clinical Lipidology

Volumn 7, Issue 2, 2013, Pages 132-139

  Blackett, Piers ^a   Tryggestad, Jeanie ^a   Krishnan, Sowmya ^a   Li, Shibo ^a   Xu, Weihong ^a   Alaupovic, Petar ^b   Quiroga, Carmen ^b   Copeland, Kenneth ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Apolipoproteins; Chylomicronemia; Familial; Gene; Lipoprotein lipase; Lipoproteins; Orlistat

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; BETA CAROTENE; LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; RETINOL; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE; VITAMIN D; VITAMIN K GROUP;

ABDOMINAL PAIN; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CHILD; CLINICAL ASSESSMENT; DIET RESTRICTION; FAMILY HISTORY; FEMALE; GENE MUTATION; HOSPITAL ADMISSION; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; LIPID BLOOD LEVEL; LOW FAT DIET; MALE; MISSENSE MUTATION; PANCREATITIS; PRIORITY JOURNAL; SCHOOL CHILD; SIBLING; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; APOLIPOPROTEINS B; CHILD; DIET, FAT-RESTRICTED; ENZYME INHIBITORS; EXONS; FEMALE; HETEROZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE I; LACTONES; LIPASE; LIPOPROTEIN LIPASE; LIPOPROTEINS, LDL; MALE; MUTATION; MUTATION, MISSENSE; PANCREATITIS; TRIGLYCERIDES;

EID: 84874108795     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2012.11.006     Document Type: Article

References (42)

1. L. Foubert, J.L. De Gennes, and J.P. Lagarde Assessment of French patients with LPL deficiency for French Canadian mutations J Med Genet 34 1997 672 675 (Pubitemid 27356887)
2. T. Gotoda, K. Shirai, and T. Ohta Diagnosis and management of type I and type V hyperlipoproteinemia J Atheroscler Thromb 19 2012 1 12
3. J.D. Brunzell, P.H. Iverius, and M.S. Scheibel Primary lipoprotein lipase deficiency Adv Exp Med Biol 201 1986 227 239
4. D. Gaudet, J. Methot, and S. Dery Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL(S447X)) gene therapy for lipoprotein lipase deficiency: an open-label trial Gene Ther 2012 in press http://dx.doi.org/ 101038/gt.2012.43
5. A.C. Carpentier, F. Frisch, and S.M. Labbe Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients J Clin Endocrinol Metab 97 2012 1635 1644
6. D. Gaudet, J. Methot, and J. Kastelein Gene therapy for lipoprotein lipase deficiency Curr Opin Lipidol 23 2012 310 320
7. P. Riepponen, J. Marniemi, and T. Rautaoja Immunoturbidimetric determination of apolipoproteins A-1 and B in serum Scand J Clin Lab Invest 47 1987 739 744 (Pubitemid 18002120)
8. P. Alaupovic, M. Tavella, and J. Fesmire Separation and identification of apo-B-containing lipoprotein particles in normolipidemic subjects and patients with hyperlipoproteinemias Adv Exp Med Biol 210 1987 7 14
9. W.J. McConathy, E. Koren, and H. Wieland Evaluation of immunoaffinity chromatography for isolating human lipoproteins containing apolipoprotein B J Chromatogr 342 1985 46 66
10. J.D. Otvos, E.J. Jeyarajah, D.W. Bennett, and R.M. Krauss Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement Clin Chem 38 1992 1632 1638
11. T. Tzotzas, G.E. Krassas, and E. Bruckert Administration of orlistat in a patient with familial hyperchylomicronemia Atherosclerosis 165 2002 185 186 (Pubitemid 35223182)
12. M.C. Tolentino, A. Ferenczi, L. Ronen, and L. Poretsky Combination of gemfibrozil and orlistat for treatment of combined hyperlipidemia with predominant hypertriglyceridemia Endocr Pract 8 2002 208 212 (Pubitemid 34555513)
13. A.S. Wierzbicki, T.M. Reynolds, and M.A. Crook Usefulness of orlistat in the treatment of severe hypertriglyceridemia Am J Cardiol 89 2002 229 231 (Pubitemid 34132918)
14. D. Brisson, J. Methot, K. Tremblay, M. Tremblay, P. Perron, and D. Gaudet Comparison of the efficacy of fibrates on hypertriglyceridemic phenotypes with different genetic and clinical characteristics Pharmacogenet Genomics 20 2010 742 747
15. M. Rouis, K.A. Dugi, and L. Previato Therapeutic response to medium-chain triglycerides and omega-3 fatty acids in a patient with the familial chylomicronemia syndrome Arterioscler Thromb Vasc Biol 17 1997 1400 1406 (Pubitemid 27329866)
16. D. Matern, H. Seydewitz, H. Niederhoff, H. Wiebusch, and M. Brandis Dyslipidaemia in a boy with recurrent abdominal pain, hypersalivation and decreased lipoprotein lipase activity Eur J Pediatr 155 1996 660 664 (Pubitemid 26232578)
17. R.M. Viner, Y. Hsia, T. Tomsic, and I.C. Wong Efficacy and safety of anti-obesity drugs in children and adolescents: systematic review and meta-analysis Obes Rev 11 2010 593 602
18. C.J. Hsieh, P.W. Wang, and R.T. Liu Orlistat for obesity: benefits beyond weight loss Diabetes Res Clin Pract 67 2005 78 83
19. J.W. Anderson Orlistat for the management of overweight individuals and obesity: a review of potential for the 60-mg, over-the-counter dosage Expert Opin Pharmacother 8 2007 1733 1742 (Pubitemid 47288178)
20. S. Henness, and C.M. Perry Orlistat: a review of its use in the management of obesity Drugs 66 2006 1625 1656 (Pubitemid 44373751)
21. J.R. McDuffie, K.A. Calis, S.L. Booth, G.I. Uwaifo, and J.A. Yanovski Effects of orlistat on fat-soluble vitamins in obese adolescents Pharmacotherapy 22 2002 814 822 (Pubitemid 34743432)
22. J.R. McDuffie, K.A. Calis, and G.I. Uwaifo Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions Obes Res 10 2002 642 650 (Pubitemid 135688263)
23. B. Gilbert, M. Rouis, S. Griglio, L. de Lumley, and P. Laplaud Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of reported mutations: 75 % are clustered in exons 5 and 6 Ann Genet 44 2001 25 32 (Pubitemid 32435636)
24. J. Peterson, A.F. Ayyobi, and Y. Ma Structural and functional consequences of missense mutations in exon 5 of the lipoprotein lipase gene J Lipid Res 43 2002 398 406 (Pubitemid 34252270)
25. B. Persson, G. Bengtsson-Olivecrona, S. Enerback, T. Olivecrona, and H. Jornvall Structural features of lipoprotein lipase. Lipase family relationships, binding interactions, non-equivalence of lipase cofactors, vitellogenin similarities and functional subdivision of lipoprotein lipase Eur J Biochem 179 1989 39 45 (Pubitemid 19097656)
26. M. Reina, J.D. Brunzell, and S.S. Deeb Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes J Lipid Res 33 1992 1823 1832 (Pubitemid 23006659)
27. C. Zheng, C. Khoo, J. Furtado, and F.M. Sacks Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype Circulation 121 2010 1722 1734
28. S. Eisenberg, J.R. Patsch, J.T. Sparrow, A.M. Gotto, and T. Olivecrona Very low density lipoprotein. Removal of apolipoproteins C-II and C-III-1 during lipolysis in vitro J Biol Chem 254 1979 12603 12608 (Pubitemid 10138186)
29. P. Alaupovic David Rubinstein Memorial Lecture: the biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins Can J Biochem 59 1981 565 579 (Pubitemid 12176312)
30. K. Tomiyasu, B.W. Walsh, K. Ikewaki, H. Judge, and F.M. Sacks Differential metabolism of human VLDL according to content of ApoE and ApoC-III Arterioscler Thromb Vasc Biol 21 2001 1494 1500 (Pubitemid 34219814)
31. Y. Tanaka, Y.C. Lin-Lee, M.H. Lin-Su, and L. Chan Intestinal biosynthesis of apolipoproteins in the rat: apoE and apoA-I mRNA translation and regulation Metabolism 31 1982 861 865 (Pubitemid 12049437)
32. T.S. Lassel, M. Guerin, S. Auboiron, M.J. Chapman, and B. Guy-Grand Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipemia in normolipidemic subjects Arterioscler Thromb Vasc Biol 18 1998 65 74 (Pubitemid 28047601)
33. A. Tall, D. Sammett, and E. Granot Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia J Clin Invest 77 1986 1163 1172 (Pubitemid 16047136)
34. B. Lamarche, K.D. Uffelman, and A. Carpentier Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men J Clin Invest 103 1999 1191 1199 (Pubitemid 29207253)
35. C.J. Bagatell, R.H. Knopp, W.W. Vale, J.E. Rivier, and W.J. Bremner Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels Ann Intern Med 116 1992 967 973
36. P. Alaupovic, W.J. Mack, C. Knight-Gibson, and H.N. Hodis The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial Arterioscler Thromb Vasc Biol 17 1997 715 722 (Pubitemid 27169133)
37. G. Steiner Lipoprotein lipase in fat-induced hyperlipemia N Engl J Med 279 1968 70 74
38. J.D. Brunzell, and H.G. Schrott The interaction of familial and secondary causes of hypertriglyceridemia: Role in pancreatitis J Clin Lipidol 6 2012 409 412
39. F.M. Sacks, P. Alaupovic, and L.A. Moye VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial Circulation 102 2000 1886 1892
40. C.O. Mendivil, E.B. Rimm, J. Furtado, S.E. Chiuve, and F.M. Sacks Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease Circulation 124 2011 2065 2072
41. P. Benlian, J.L. De Gennes, L. Foubert, H. Zhang, S.E. Gagne, and M. Hayden Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene N Engl J Med 335 1996 848 854 (Pubitemid 26304066)
42. S.P. Babirak, B.G. Brown, and J.D. Brunzell Familial combined hyperlipidemia and abnormal lipoprotein lipase Arterioscler Thromb 12 1992 1176 1183